What is the official website of Morton LTC ?

The official website of Morton LTC is http://mortonltc.com.

What is Morton LTC's cybersecurity risk score?

Morton LTC has an AI-generated cybersecurity risk score of 593 out of 1000, indicating a Very Poor security posture according to Rankiteo's assessment.

How many security incidents has Morton LTC experienced?

According to Rankiteo, Morton LTC currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Morton LTC been affected by any supply chain cyber incidents ?

According to Rankiteo, Morton LTC has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Morton LTC have SOC 2 Type 1 certification ?

According to Rankiteo, Morton LTC is not certified under SOC 2 Type 1.

Does Morton LTC have SOC 2 Type 2 certification ?

According to Rankiteo, Morton LTC does not hold a SOC 2 Type 2 certification.

Does Morton LTC comply with GDPR ?

According to Rankiteo, Morton LTC is not listed as GDPR compliant.

Does Morton LTC have PCI DSS certification ?

According to Rankiteo, Morton LTC does not currently maintain PCI DSS compliance.

Does Morton LTC comply with HIPAA ?

According to Rankiteo, Morton LTC is not compliant with HIPAA regulations.

Does Morton LTC have ISO 27001 certification ?

According to Rankiteo,Morton LTC is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Morton LTC operate in ?

Morton LTC operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Morton LTC have ?

Morton LTC employs approximately 40 people worldwide.

Does Morton LTC own any subsidiaries ?

Morton LTC presently has no subsidiaries across any sectors.

How many LinkedIn followers does Morton LTC have ?

Morton LTC's official LinkedIn profile has approximately 219 followers.

What is the NAICS classification code for Morton LTC ?

Morton LTC is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Morton LTC have a Crunchbase profile ?

No, Morton LTC does not have a profile on Crunchbase.

Does Morton LTC have a LinkedIn profile ?

Yes, Morton LTC maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/morton-ltc.

How many cybersecurity incidents has Morton LTC experienced ?

As of September 2, 2026, Rankiteo reports that Morton LTC has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Morton LTC have ?

Morton LTC has an estimated 5,750 peer or competitor companies worldwide.

What types of cybersecurity incidents has Morton LTC faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Morton LTC

Boost Score +25 with badge (5 left)

593

/1000

Very Poor

618

/1000

Poor

Morton LTC Vendor Cyber Rating & Cyber Score

mortonltc.com

Add Your Compliance Badge

Morton LTC is an independent fourth-generation family-owned Wisconsin pharmacy. In 2011 Morton Pharmacy restructured to focus entirely on providing pharmacy solutions to long term care providers. Morton LTC offers its customers the expertise of knowledgeable directly-employed consultant pharmacists coupled with leading edge technogoly and a friendly, effiecient customer service team.

Morton LTC A.I CyberSecurity Scoring

Scoring History

Morton LTC

Morton LTC CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Morton LTC

Breach

12/2025

MOR1765232510

Morton LTC

Breach

8/2025

MOR1764807261

Loading…

A.I.

Morton LTC Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Morton LTC

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Morton LTC in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Morton LTC in 2026.

Incident Types Morton LTC vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Morton LTC in 2026.

Incident History - Morton LTC (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Morton LTC Subsidiaries

Parent Company

Morton LTC

Pharmaceutical Manufacturing

Website: http://mortonltc.com

Company Size: 51-200 employees

No subsidiary data available for this company.

Loading…

Morton LTC Similar Companies

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Loading…

NEWS

Morton LTC CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

December 10, 2025 08:00 AM

Data Breaches Announced by Morton Drug Company & Physicians to Children & Adolescents

Data breaches have been announced by Morton Drug Company in Wisconsin, Physicians to Children & Adolescents in Kentucky, and the Center for...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-84483

SUMMARY

WWBN AVideo through commit 9c39d8c8 contains an incomplete authentication bypass in encryptPass.json.php that allows unauthenticated attackers to compute valid HMAC tokens using the public site URL and current time. Attackers can forge authentication tokens by computing hash_hmac with the site's base URL as the key and submit arbitrary passwords to receive encrypted hashes, enabling offline precomputation attacks against stolen password databases.

Published

Date2026-09-01

Updated

Date2026-09-01

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-84482

SUMMARY

WWBN AVideo through commit 9c39d8c8 contains a cross-site request forgery vulnerability in the get_domain() and isSameDomain() functions that fail to properly validate referer origins. Attackers can forge requests from sibling subdomains or unparseable long-gTLD origins to perform administrative ObjectYPT writes including live server configuration changes.

Published

Date2026-09-01

Updated

Date2026-09-01

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.8

REFERENCES

CVE-2026-84481

SUMMARY

WWBN AVideo through 30.0 contains an information disclosure vulnerability in the MobileManager plugin getConfiguration endpoint that returns sensitive configuration data to unauthenticated visitors. Attackers can send an unauthenticated GET request to plugin/MobileManager/getConfiguration.json.php to obtain TLS private key file paths, socket configuration details, platform version, and debug flags enabling further targeted attacks.

Published

Date2026-09-01

Updated

Date2026-09-01

RISK INFORMATION (Score: )

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-84480

SUMMARY

WWBN AVideo fails to validate password recovery token expiration in userRecoverPassSave.json.php, allowing attackers to use expired tokens to reset account passwords indefinitely. Attackers who obtain a recovery token can use it at any time to change the target account's password and gain full account access.

Published

Date2026-09-01

Updated

Date2026-09-01

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

3.9

REFERENCES

CVE-2026-84479

SUMMARY

WWBN AVideo (current e01e41ecc and earlier) makes three login-time security controls depend solely on the client-supplied User-Agent header. The isAVideoEncoder()/isAVideoMobileApp() checks match HTTP_USER_AGENT against a hardcoded literal ("AVideoEncoder"/"AVideoMobileApp") with no IP check or shared secret. An attacker who submits valid credentials and sets User-Agent: AVideoEncoder bypasses two-factor authentication, skips brute-force captcha escalation, and avoids being recorded in the login/device audit history. No patch is available at the time of publication.

Published

Date2026-09-01

Updated

Date2026-09-01

RISK INFORMATION (Score: 9.1)

cvss3

Base Score: 9.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…